Fig. 3

Clinical parameters and genomic alterations correlates of metabolic subtypes. a–c Kaplan–Meier survival analyses demonstrating poorer overall survival in glycan-HCC versus lipid-HCC in TCGA (a), ICGC (b), and CPTAC (c) cohorts. Survival plots were generated by using R package “survminer”. d Heatmap showing associations between metabolic subtypes, clinical parameters, and mutational profiles. e Genomic instability metrics (aneuploidy/CNA/HRD scores) were elevated in glycan-HCC, and tumor mutation burden showed no significant difference